Discovery® Antibodies is the new catalogue antibody business from Cambridge Research Biochemicals (CRB).
CRB, the 2nd oldest peptide company in the world and forerunner in the antibody research market has had a 22 year break (1994-2016) from a catalogue business and now in it’s 37th year (2017) is celebrating by launching a brand new off-the-shelf antibody business called Discovery® Antibodies. Discovery® Antibodies will focus on antibodies for research (early drug ‘discovery’) and will complement our very successful and long-standing custom antibody business (www.crbdiscovery.com). We are already well known for novel, complex, rare and post-translational modification specific antibodies and these sought after targets will feature in our Discovery® Antibody catalogue range. We launched our Discovery® Antibodies in February 2017 a year after Discovery® Peptides and some 240 years after Captain James Cook, (the greatest explorer of his time) set off in 1776 from England aboard the ‘HMS Discovery’ to charter new waters and ‘discover’ new lands around the globe. Thus the name ‘Discovery’ seemed fitting to a North-East-based manufacturer – the home town of James Cook. Further parallels arise between the quest for new found lands around the world in the late 1700s and new ‘discoveries’ in medical research and the mapping of the human genome in 2000.
Cambridge Research Biochemicals
17-18 Belasis Court, Belasis Hall Technology Park
Billingham, Cleveland, TS23 4AZ U.K.
P: +44 (0)1642 567 183